Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Hyun‐Ae Jung"'
Autor:
Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh
Publikováno v:
Supportive Care in Cancer. 30:7431-7438
A multicenter prospective study to evaluate the feasibility of Physician Orders for Life-Sustaining Treatment (POLST) in oncology practice was conducted between June and December 2017. Factors associated with POLST completion and follow-up outcomes w
Autor:
Sehhoon Park, Jin Seok Ahn, Jong-Mu Sun, Myung-Ju Ahn, Hyun Ae Jung, Keunchil Park, Hongsik Kim, Se-Hoon Lee
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Metachronous brain-only oligorecurrence in patients with non–small cell lung cancer (NSCLC) is a rare event with favorable prognosis, but the clinical outcome has not been fully determined. We retrospectively analyzed clinical outcomes and
Publikováno v:
PloS one. 17(10)
Background Oropharyngeal squamous cell carcinoma (OPSCC) is the most common neoplasm originating at the base of the tongue or in the tonsils or soft palate. In this study, we investigated the prognostic value of FOXP3+ regulatory T cells in OPSCC. Me
Autor:
Binnari Kim, Hyun Ae Jung, Se-Hoon Lee, Myung-Ju Ahn, Minsuk Kwon, Jong-Mu Sun, Hyera Kim, Keunchil Park
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background Anti-PD1 inhibitors have been approved for the treatment of recurrent or metastatic head and neck cancer (HNC), as a result of Global Phase III trials. However, the clinical outcomes of immune checkpoint inhibitors in patients who are not
Publikováno v:
Lung Cancer. 146:112-119
Introduction Until the recent approval of immunotherapy after completing concurrent chemoradiotherapy (CCRT), there has been little progress in treating unresectable stage III non-small cell lung cancer (NSCLC). This prompted us to search real-world
Autor:
Robert E. Godin, Jin Seok Ahn, Joon Ho Shim, Myung-Ju Ahn, Keunchil Park, Hyun Ae Jung, Peter S. Mortimer, Jong-Mu Sun, Sehhoon Park, Woong-Yang Park, Simon Smith, Se-Hoon Lee, Simon J. Hollingsworth, Heejung (Rosa) Kim
Publikováno v:
Cancer. 126:4002-4012
Background A high percentage of small cell lung cancer (SCLC) cases harbor cell cycle-related gene mutations and RICTOR amplification. Based on underlying somatic mutations, the authors have conducted a phase 2 biomarker-driven, multiarm umbrella stu
Autor:
Hyun Ae Jung, Yunjoo Im, Keunchil Park, Jong-Mu Sun, Se-Hoon Lee, Sun Hye Shin, Jin Seok Ahn, Myung-Ju Ahn, Hye Yun Park, Ho Yun Lee
Publikováno v:
International Journal of Cancer. 145:2433-2439
Emerging immune profiling data suggest a higher sensitivity to immune checkpoint inhibitors (ICIs) in nonsmall cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD), compared to those without COPD. This study aimed to in
Autor:
Hyun Ae Jung, Jung Yong Hong, Moon Ki Choi, Won Jin Chang, Sung-min Kim, Moon Jin Kim, Keunchil Park, Hye Sook Kim, Jong-Mu Sun, Myung-Ju Ahn
Publikováno v:
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine, Vol 34, Iss 5, Pp 1107-1115 (2019)
The Korean Journal of Internal Medicine, Vol 34, Iss 5, Pp 1107-1115 (2019)
Background/Aims We investigated the efficacy and toxicity of a weekly schedule of docetaxel and cisplatin as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Methods In this study, 18
Autor:
Hyun Ae Jung, Ho Young Kim, Hyun Chang, Hunho Song, Se Hoon Park, Jung Hoon Kim, Jae Ho Byun, Byeong Seok Sohn, Inkeun Park, Kyung Hee Lee, Woo Kyun Bae, Chi Hoon Maeng, Seungtaek Lim, Jung A. Kim, Hyo Jin Lee, Do Hyoung Lim, Sung-min Kim, Hee Jun Kim
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5431-5437 (2019)
Cancer Medicine
Cancer Medicine
The regional lymph node‐positive bladder cancer was classified as stage IV in the AJCC 7th edition but was changed to stage IIIB in the 8th edition, revised in 2018. Among the various studies involving immune checkpoint inhibitors, groups that had
Publikováno v:
Chemotherapy
Background and Aims: Although pancreatic cancers are common in older age-groups, the prognosis remains poor due to limited studies on treatment approaches and outcomes in a given population. We aimed to examine treatment patterns and their outcomes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c350ae99dc07552f7ff803bd05d219a7
https://europepmc.org/articles/PMC8619775/
https://europepmc.org/articles/PMC8619775/